Pomerantz investigates Nutex Health for securities fraud allegations.
ByAinvest
Saturday, Aug 9, 2025 11:57 am ET1min read
EXC--
The investigation was prompted by a critical report issued by Blue Orca Capital on July 22, 2025, which alleged that Nutex's use of HaloMD as an independent dispute resolution (IDR) vendor may have led to misleading disclosures and improper revenue recognition. The report also noted that Nutex's stock price fell by 10.05% on July 22, 2025, closing at $100.01 per share, following the publication of the report [2].
Nutex's use of HaloMD and its impact on the company's financial statements have come under scrutiny. The No Surprises Act (NSA), implemented in 2022, has had a significant impact on Nutex's revenue, leading to substantial operating and net losses in 2022 and 2023. Nutex's market capitalization has plummeted to less than $30 million as a result [3].
Investors who purchased Nutex stock and believe they have suffered substantial losses are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980, to participate in the investigation or learn more about the claims [2].
References:
[1] https://www.morningstar.com/news/business-wire/20250808663025/securities-fraud-investigation-into-marex-group-plc-mrx-announced-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-a-leading-securities-fraud-law-firm
[2] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nutex-health-inc---nutx-302521624.html
[3] https://www.morningstar.com/news/globe-newswire/9506826/nutex-health-nutx-shares-fall-amid-critical-blue-orca-report-hagens-berman
MORN--
MRX--
NUTX--
Pomerantz LLP is investigating claims of securities fraud against Nutex Health Inc. (NASDAQ: NUTX). The investigation concerns Nutex's relationship with HaloMD, a third-party vendor recently sued for allegedly engaging in a fraudulent scheme. Following a short report by Blue Orca Capital, Nutex's stock price fell 10.05%. Investors who purchased NUTX stock are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Nutex Health Inc. (NASDAQ: NUTX) is facing a securities fraud investigation by Pomerantz LLP, a prominent law firm specializing in corporate, securities, and antitrust class litigation. The investigation centers around Nutex's relationship with HaloMD, a third-party vendor that has recently been the subject of lawsuits alleging fraudulent schemes.The investigation was prompted by a critical report issued by Blue Orca Capital on July 22, 2025, which alleged that Nutex's use of HaloMD as an independent dispute resolution (IDR) vendor may have led to misleading disclosures and improper revenue recognition. The report also noted that Nutex's stock price fell by 10.05% on July 22, 2025, closing at $100.01 per share, following the publication of the report [2].
Nutex's use of HaloMD and its impact on the company's financial statements have come under scrutiny. The No Surprises Act (NSA), implemented in 2022, has had a significant impact on Nutex's revenue, leading to substantial operating and net losses in 2022 and 2023. Nutex's market capitalization has plummeted to less than $30 million as a result [3].
Investors who purchased Nutex stock and believe they have suffered substantial losses are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980, to participate in the investigation or learn more about the claims [2].
References:
[1] https://www.morningstar.com/news/business-wire/20250808663025/securities-fraud-investigation-into-marex-group-plc-mrx-announced-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-a-leading-securities-fraud-law-firm
[2] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nutex-health-inc---nutx-302521624.html
[3] https://www.morningstar.com/news/globe-newswire/9506826/nutex-health-nutx-shares-fall-amid-critical-blue-orca-report-hagens-berman
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet